Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DB25FKEFN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,782
Award facts
- Contract value 100% obligated
- $12,782.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,782.32 to DMS Pharmaceutical Group Inc. on May 7, 2025, for the supply of Alecensa 150 mg capsules (240 count). This firm fixed-price delivery order, which is not set-aside designated, will be fulfilled at the contractor's facility in Park Ridge, Illinois, with an ultimate completion date of May 29, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, has been registered in SAM.gov since 2001 and specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to federal agencies.
This delivery order is issued under DMS Pharmaceutical Group's significant Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables DLA to procure a comprehensive range of pharmaceutical products supporting medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a consistent portfolio of contract awards for specialty pharmaceuticals and medical supplies to Department of Defense healthcare sites, positioning the company as a key distributor for oncology treatments, specialty injections, and other prescription medications.
Quick answers
Who was awarded contract SPE2DB25FKEFN?
SPE2DB25FKEFN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 7, 2025.
How much is contract SPE2DB25FKEFN worth?
The government has obligated $12,782 on SPE2DB25FKEFN.
Is contract SPE2DB25FKEFN an order under another contract?
Yes. SPE2DB25FKEFN is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEFN competed?
The extent of competition for SPE2DB25FKEFN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award